Schwarz R T, Klenk H D
J Virol. 1974 Nov;14(5):1023-34. doi: 10.1128/JVI.14.5.1023-1034.1974.
d-Glucosamine and 2-deoxy-d-glucose interfere with the biosynthesis of the hemagglutinin glycoproteins. With increasing inhibitor concentrations a progressive decrease in size of the precursor HA and the cleavage products, HA(1) and HA(2) can be observed. The shift in molecular weight is paralleled by a decrease of the carbohydrate content. This was shown by labeling studies with radioactive sugars which revealed that the inhibitors block the incorporation into glycoproteins, whereas they have no or only slight effects on the uptake and activation of sugars. Under conditions of maximal inhibition, the hemagglutinin proteins lack all or most of their carbohydrates. These findings indicate that the inhibitory effect of d-glucosamine and 2-deoxy-d-glucose is due to an impairment of glycosylation. When glycosylation is inhibited, the precursor polypeptide is synthesized at normal rates. Its cleavage products, however, are very heterogeneous. This suggests that carbohydrate protects the hemagglutinin from proteolytic degradation.
D-葡萄糖胺和2-脱氧-D-葡萄糖会干扰血凝素糖蛋白的生物合成。随着抑制剂浓度的增加,可以观察到前体HA及其裂解产物HA(1)和HA(2)的大小逐渐减小。分子量的变化与碳水化合物含量的减少平行。用放射性糖进行的标记研究表明了这一点,该研究揭示抑制剂会阻止糖掺入糖蛋白中,而它们对糖的摄取和活化没有影响或只有轻微影响。在最大抑制条件下,血凝素蛋白缺乏全部或大部分碳水化合物。这些发现表明D-葡萄糖胺和2-脱氧-D-葡萄糖的抑制作用是由于糖基化受损。当糖基化受到抑制时,前体多肽以正常速率合成。然而,其裂解产物非常不均一。这表明碳水化合物可保护血凝素免受蛋白水解降解。